David M Rapoport, MD
- PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Specialties:
Sleep Medicine, Internal Medicine, Pulmonary MedicineAfter receiving an undergraduate degree in Physics at the Massachusetts Institute of Technology, Dr. Rapoport attended the Albert Einstein College of Medicine and received his M.D. in 1974. He did his Internal Medicine training at the Roosevelt Hospital and a Pulmonary Fellowship at New York University Medical Center/Bellevue. He has been involved in clinical research in Sleep Medicine since 1979 and is currently the Director of the Sleep Medicine Research Program at Mount Sinai. Dr. Rapoport has a longstanding interest in the physiology of sleep disordered breathing (sleep apnea and snoring). He was one of the early users and developers of nasal CPAP as a treatment for sleep apnea. He holds multiple U.S. and European patents for improvements on nasal CPAP. Dr. Rapoport is the founder and President of the Foundation for Research in Sleep Disorders. This non-profit organization supports sleep research through grants and fellowship stipends, and has contributed to the education of future sleep scientists and to funding research leading to development of new diagnostic and therapeutic techniques in sleep medicine. He is also a member of the Board of Directors of the American Sleep Apnea Association and formerly of the American Lung Association of the City of New York.
Certifications
Pulmonary Disease
American Board of Internal Medicine
Education
MD, Albert Einstein College of Medicine
Residency, Internal Medicine, St Lukes Roosevelt Hospital
Fellowship, Pulmonary Disease, NYU Medical Center
Aging, Alzheimer's Disease, Brain, Brain Imaging, Imaging, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology, Memory, Neural Networks, Neurobiology, Neuromuscular System, Neurophysiology, Neuroscience, Respiratory Tract, Systems Biology, Systems Neuroscience
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Rapoport did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.